School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Hong Kong.
Nethersole School of Nursing, The Chinese University of Hong Kong, Shatin, Hong Kong.
BMC Palliat Care. 2024 Nov 7;23(1):257. doi: 10.1186/s12904-024-01588-z.
Advance care planning (ACP) is a well-recognized quality indicator for palliative care. Despite two decades of effort, previous studies showed that ACP-related documentation and end-of-life discussion rates remain low for palliative care patients. Although ACP is about self-determination and autonomy, studies consistently show the importance of family involvement in adult patient's medical decision-making. Yet, research on ACP interventions with structured components targeting family member remained limited. The current study aims to evaluate the effectiveness of a structured, family-supported, patient-centred ACP programme for adult palliative care patients and their families.
This is a 2-arm parallel group randomized controlled trial with follow-ups at 6 and 12 months. One hundred and seventy eligible palliative care patients and their families are planned to be recruited from three hospitals, and randomized to either a structured, family-supported, patient-centred ACP programme (ACP-Family) or usual ACP care (ACP-UC) arm. The ACP-Family intervention consists of 2 sessions. The primary outcome is family's prediction accuracy of patient's treatment preferences at 6 months. Secondary outcomes include proportions of new ACP documentations and family-reported perception of whether the patient's end-of-life (EOL) care preference was respected; patient's decisional conflict; quality of communication; family's decision-making confidence; family's anxiety and depression; and patients' and family members' satisfaction of the intervention. Outcomes of the two groups will be compared using regressions and linear mixed-effects models.
This study will provide rigorous scientific evidence on the effectiveness of a structured and well-design family-supported, patient-centred ACP programme for adult palliative care patients and their family members in the hospital setting. If the ACP-Family proves to be effective, it will provide a structured and systematic approach to facilitate ACP discussions involving family members. This will respond to local needs and inform international ACP practice.
ClinicalTrials.gov Identifier: NCT05935540.
预先医疗照护计划(ACP)是缓和医疗的一项公认的质量指标。尽管已经努力了二十年,但先前的研究表明,缓和医疗患者的 ACP 相关文件记录和临终讨论率仍然很低。尽管 ACP 是关于自主和自主权的,但研究一致表明,家庭成员在成年患者的医疗决策中发挥重要作用。然而,针对有结构组成部分的、以家庭成员为目标的 ACP 干预措施的研究仍然有限。本研究旨在评估一种针对成年缓和医疗患者及其家属的结构化、家庭支持、以患者为中心的 ACP 计划的有效性。
这是一项 2 臂平行组随机对照试验,随访时间为 6 个月和 12 个月。计划从三家医院招募 170 名符合条件的缓和医疗患者及其家属,并随机分配到结构化、家庭支持、以患者为中心的 ACP 计划(ACP-Family)或常规 ACP 护理(ACP-UC)组。ACP-Family 干预包括 2 个阶段。主要结局是家庭在 6 个月时对患者治疗偏好的预测准确性。次要结局包括新的 ACP 文件记录的比例以及家庭报告患者的临终关怀偏好是否得到尊重的情况;患者的决策冲突;沟通质量;家庭的决策信心;家庭的焦虑和抑郁;以及患者和家属对干预的满意度。将使用回归和线性混合效应模型比较两组的结果。
本研究将为医院环境中针对成年缓和医疗患者及其家属的结构化、精心设计的家庭支持、以患者为中心的 ACP 计划的有效性提供严格的科学证据。如果 ACP-Family 被证明有效,它将为促进涉及家庭成员的 ACP 讨论提供一种结构化和系统的方法。这将满足当地的需求,并为国际 ACP 实践提供信息。
ClinicalTrials.gov 标识符:NCT05935540。